The Flowr Corporation (TSXV: FLWR) (“Flowr” or “the Company”), a
Canadian Licensed Producer of premium cannabis products, will
release financial results for its third quarter and the nine months
ended September 30, 2018 on November 28, 2018.
This is Flowr’s first report of financial results since the
completion of its going-public transaction on September 21,
2018. Flowr’s results for these periods do not include any
sales of cannabis products as the Company received its sales and
production license in August 2018.
Flowr will host a conference call for investors on November 29
at 9:00am EST with Vinay Tolia and Tom Flow, Co-CEOs, and Alex
Dann, CFO.
Conference Call Information
Toll Free Dial-in: 1-888-556-3059
International Dial-in: 1-409-983-9742
Conference ID: 4079223
Replay Information
A replay of the call will be available until 11:59pm Eastern
Time, December 12, 2018 by dialing 1-800-585-8367 or 1-404-537-3406
and entering conference code 4079223.
About Flowr
The Flowr Corporation (TSXV: FLWR), through its subsidiaries,
holds a cannabis production and sales license granted by Health
Canada. With a head office in Markham, ON and a production
facility in Kelowna, BC, Flowr builds and operates large-scale,
GMP-designed cultivation facilities utilizing its own patented
growing systems. Flowr’s investment in research and
development along with its sense of craftsmanship and a spirit of
innovation is expected to enable it to provide premium-quality
cannabis that appeals to the adult-use recreational market and
addresses specific patient needs in the medicinal market.
For more information, visit www.flowr.ca Follow Flowr on
Twitter: @FlowrCanada; Facebook: Flowr Canada; Instagram:
@flowrcanada; and LinkedIn: The Flowr Corporation
On behalf of The Flowr Corporation:
Alex Dann
Chief Financial Officer
Forward-Looking Information
This press release includes forward-looking information within
the meaning of Canadian securities laws regarding Flowr and its
business, which may include, but are not limited to:
statements with respect to the release date of Flowr's financial results,
Flowr’s investment in research and development along with its sense
of craftsmanship and a spirit of innovation enabling it to provide
premium-quality cannabis that appeal to the adult-use recreational
market and address specific patient needs in the medicinal market
and other factors. Often, but not always, forward-looking
information can be identified by the use of words such as “plans”,
“is expected”, “expects”, “scheduled”, “intends”, “contemplates”,
“anticipates”, “believes”, “proposes” or variations (including
negative and grammatical variations) of such words and phrases, or
state that certain actions, events or results “may”, “could”,
“would”, “might” or “will” be taken, occur or be achieved. Such
statements are based on the current expectations of Flowr’s
management and are based on assumptions and subject to risks and
uncertainties. Although Flowr’s management believes that the
assumptions underlying these statements are reasonable, they may
prove to be incorrect. The forward-looking events and circumstances
discussed in this press release may not occur by certain specified
dates or at all and could differ materially as a result of known
and unknown risk factors and uncertainties affecting Flowr,
including risks associated with a delay
in releasing Flowr’s financial statements (which could result in a violation
of applicable laws), Flowr not being able to sustain its
competitive advantage in cultivation and being unable to remain at
the forefront of industry innovation, whether as a result of failed
construction of the facilities or otherwise, Flowr not being able
to meet demand or fulfill purchase orders, which could materially
impact revenues and its relationships with purchasers, Flowr
requiring additional financing from time to time in order to
continue its operations and such financing may not be available
when needed or on terms and conditions acceptable to the Company,
new laws or regulations adversely affecting the Company’s business
and results of operations, results of operation activities and
development of projects, project cost overruns or unanticipated
costs and expenses, the inability of Flowr’s products to
be high quality, the inability of Flowr’s products to appeal to the
adult-use recreational market and address specific patient needs in
the medicinal market, the inability of Flowr to produce and
distribute premium, high quality products, the inability to supply
products or any delay in such supply, Flowr’s securities, the
inability to generate cash flows, revenues and/or stable margins,
the inability to grow organically, risks associated with the
geographic markets in which Flowr operates and/or distributes its
products, risks associated with fluctuations in exchange rates
(including, without limitation, fluctuations in currencies), risks
associated with the use of Flowr’s products to treat certain
conditions, the cannabis industry and the regulation thereof, the
failure to comply with applicable laws, risks relating to
partnership arrangements, possible failure to realize the
anticipated benefits of partnership arrangements, product launches
(including, without limitation, unsuccessful product launches), the
inability to launch products, the failure to obtain regulatory
approvals, economic factors, market conditions, risks associated
with the acquisition and/or launch of products, the equity and debt
markets generally, risks associated with growth and competition
(including, without limitation, with respect to Flowr’s products),
general economic and stock market conditions, risks and
uncertainties detailed from time to time in Flowr’s filings with
the Canadian Securities Administrators and many other factors
beyond the control of Flowr. Although Flowr has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking information, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. No forward-looking information can be
guaranteed. Except as required by applicable securities laws,
forward-looking information speaks only as of the date on which it
is made and Flowr undertakes no obligation to publicly update or
revise any forward-looking information, whether as a result of new
information, future events, or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this press release.
- ends -
Jim Walsh
The Flowr Corporation
+1-607-275-7141
jwalsh@flowr.ca
Bruce Dunbar
The Flowr Corporation
+1-917-756-4065
bdunbar@flowr.ca
For Investors Only: Alex Dann, CFO
The Flowr Corporation
+1-416-464-4067
adann@flowr.ca
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Apr 2024 to May 2024
The Flowr (TSXV:FLWR)
Historical Stock Chart
From May 2023 to May 2024